Anti-MMP-11 Rabbit Polyclonal Antibody

Rabbit Polyclonal
WB
Citation tracking pending
Rabbit polyclonal antibody raised against the hemopexin domain of human MMP-11 (Stromelysin-3), validated for Western blot.
Host
Rabbit, Polyclonal
Reactivity
Validated- Human Potential-Mouse, Rat, Pan, Monkey, Dog
UniProt
P24347
Size
100ug
Cat. #
RP2MMP11

In stock

SKU
RP-MMP11

Options

As low as: $130.00

Target Overview

Matrix metalloproteinase-11 (MMP-11, Stromelysin-3, UniProt P24347) is a secreted zinc-dependent endopeptidase belonging to the stromelysin subfamily of the matrix metalloproteinase family (EC 3.4.24.-). Unlike most MMPs, MMP-11 is not efficiently secreted in its active form and exhibits restricted substrate specificity compared to stromelysins-1 and -2. The 488-amino acid protein is expressed primarily by stromal fibroblasts rather than epithelial cells and localizes to the extracellular matrix. MMP-11 is distinguished by its inefficient activation by conventional proteinases and minimal activity against classical MMP substrates such as collagens and laminins. The enzyme contains a catalytic domain and a C-terminal hemopexin domain, the latter being critical for substrate recognition and protein-protein interactions. MMP-11 plays a documented role in tissue remodeling during embryonic development and wound healing, but is best characterized for its upregulation in the tumor stroma of various carcinomas, where it may facilitate malignant progression through mechanisms beyond simple matrix degradation.

Background

MMP-11 was initially identified as a gene overexpressed in breast carcinomas and has since been implicated in the progression of multiple epithelial malignancies. Its stromal expression pattern distinguishes it from most MMPs, which are typically produced by tumor cells themselves. Evidence suggests that MMP-11 contributes to cancer progression not through direct extracellular matrix proteolysis, but via cleavage of protease inhibitors such as alpha-1-proteinase inhibitor and insulin-like growth factor binding proteins, thereby modulating the tumor microenvironment. Recent work has expanded understanding of MMP-11 function in stromal remodeling across diverse pathological contexts. Yu et al (2026) demonstrated that stromal remodeling pathways, including those involving matrix metalloproteinases, are modulated during combination chemoimmunotherapy in esophageal cancer, suggesting that stromal proteolytic networks respond dynamically to therapeutic intervention. Santos et al (2026) investigated transcriptional regulation of metalloproteinases during lung cancer cell migration, finding that natural compounds can suppress MMP expression in both two-dimensional and three-dimensional culture systems, reinforcing the relevance of MMPs in cancer cell motility and invasion. MMP-11 expression has been associated with poor prognosis in breast, ovarian, and colorectal cancers, making it a target of interest for both mechanistic studies and biomarker development. The enzyme is synthesized as a zymogen (proMMP-11) that requires furin-like proprotein convertases for intracellular activation, unlike most MMPs which are activated extracellularly. This unusual activation mechanism and restricted substrate profile have made MMP-11 challenging to study biochemically. Triple Point Biologics offers four rabbit polyclonal antibodies targeting the hemopexin domain of MMP-11, validated for Western blot applications in human samples, with predicted cross-reactivity in mouse, rat, primate, and canine tissues. These reagents enable detection of both pro- and active forms of the enzyme in tissue lysates and paraffin-embedded specimens.

References

  1. Yu Z et al (2026) Targeting VEGF signaling and stromal remodeling enhances chemoimmunotherapy efficacy in esophageal cancer. J Immunother Cancer. PubMed · 10.1136/jitc-2025-014249
  2. Santos AGPD et al (2026) Modulatory Effects of Cirsimarin on Lung Cancer A549 Cells Migration in 2D and 3D Cultures Involves Transcriptional Regulation of Metalloproteinases. J Biochem Mol Toxicol. PubMed · 10.1002/jbt.70772

Additional Specifications

Gene Symbol MMP11
UniProt ID P24347
Host Species Rabbit
Species Reactivity Validated- Human
Potential-Mouse, Rat, Pan, Monkey, Dog
Pack Size 100ug
Immunogen (Hemopexin domain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 288-488.
Immunogen (Hinge region)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 266-290.
Immunogen (Carboxyterminal end)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 438-488.
Immunogen (Propeptide region)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 32-97.
Alternate Names Matrix metalloproteinase-11, Stromelysin-3, MMP-11, SL-3, ST3, EC 3.4.24.-

Frequently Asked Questions

What molecular weight band should I expect for MMP-11 on a Western blot?

MMP-11 migrates at approximately 51 kDa in its proenzyme form and around 44 kDa when activated. Because MMP-11 is not efficiently secreted in its active form and undergoes intracellular processing, you will typically detect the 51 kDa pro-MMP-11 band in cell lysates and conditioned media. In stromal fibroblast samples, the proform is predominant. If you observe multiple bands, consider that MMP-11 can be glycosylated, which may shift migration slightly. We recommend running a positive control lysate from MMP-11-expressing fibroblasts to confirm the expected pattern in your system.

What is the recommended starting dilution for this MMP-11 antibody in Western blot?

We recommend starting at 1:1000 dilution in blocking buffer for Western blot applications. This polyclonal antibody has been validated at this dilution in human samples. Depending on your expression levels and detection system sensitivity, you may need to optimize between 1:500 and 1:2000. MMP-11 is typically expressed at low levels by stromal fibroblasts rather than epithelial cells, so enriched stromal samples or longer exposure times may be necessary. Always include a no-primary-antibody control to assess background, and consider concentrating conditioned media if detecting secreted MMP-11.

Does this antibody work for mouse and rat MMP-11 detection?

This antibody has validated reactivity against human MMP-11 and predicted cross-reactivity with mouse and rat based on sequence homology. Human MMP-11 shares approximately 80 percent identity with mouse and rat orthologs, primarily in the catalytic and hemopexin domains where this polyclonal was likely raised. We recommend empirically testing the antibody at 1:1000 dilution in your rodent samples and running a human positive control in parallel. If signal is weak, titrate to 1:500. Cross-reactivity is not guaranteed without direct validation, so plan to include species-matched controls in your initial optimization experiments.

What sample types are best for detecting endogenous MMP-11 expression?

MMP-11 is expressed predominantly by stromal fibroblasts in tissues undergoing remodeling, not by epithelial cells, which distinguishes it from most other MMPs. For Western blot, fibroblast cultures, tumor stroma, or whole-tissue lysates enriched in connective tissue yield the strongest signal. Conditioned media from fibroblast cultures can also be used, though MMP-11 secretion is less efficient than other MMPs. For IHC, breast carcinoma stroma, wound-healing tissue, and fibrotic samples are positive controls. Avoid expecting robust signal in purely epithelial cell lines or lysates, as MMP-11 expression is typically absent or very low in those contexts.

Will this antibody detect both pro-MMP-11 and active MMP-11?

This polyclonal antibody is raised against a large fragment of MMP-11, likely spanning the catalytic domain, so it should recognize both the 51 kDa proenzyme and the 44 kDa active form. However, because MMP-11 is inefficiently activated and the proform is predominant in most biological samples, you will usually detect the 51 kDa band. Active MMP-11 may be present at low levels in specialized contexts such as tumor stroma or remodeling tissue. If you need to distinguish pro- from active forms, run reducing SDS-PAGE and compare migration to recombinant standards of known activation state.

What are appropriate positive and negative controls for MMP-11 experiments?

For positive controls, use lysates from primary human fibroblasts, particularly those stimulated with TGF-beta or cultured in three-dimensional collagen matrices, which upregulate MMP-11 expression. Tumor-associated fibroblast lines or breast carcinoma tissue lysates also work well. Recombinant human MMP-11 protein is a reliable standard for confirming antibody specificity and expected molecular weight. For negative controls, use epithelial cell lines with negligible MMP-11 expression or fibroblasts from MMP-11 knockout mice if available. A no-primary-antibody control lane is essential to rule out non-specific secondary antibody binding in your detection system.

How should I store this MMP-11 antibody and what is its stability after reconstitution?

Store the lyophilized antibody at minus twenty degrees Celsius until reconstitution. Once reconstituted in sterile phosphate-buffered saline or the buffer of your choice, aliquot immediately to avoid repeated freeze-thaw cycles and store aliquots at minus twenty or minus eighty degrees Celsius. Rabbit polyclonal antibodies targeting proteinases are generally stable for at least twelve months under these conditions. Avoid storing diluted working solutions; prepare fresh dilutions in blocking buffer for each experiment. If you observe reduced signal intensity or increased background over time, thaw a fresh aliquot rather than re-using a working stock. Do not store in frost-free freezers due to temperature cycling.

Why is MMP-11 substrate specificity different from other stromelysins?

MMP-11 exhibits restricted substrate specificity compared to stromelysins-1 and -2 and shows minimal activity against classical MMP substrates such as collagens, laminins, and fibronectin. This difference arises from structural features in its catalytic domain and inefficient activation by conventional proteinases. MMP-11 substrates include alpha-1-proteinase inhibitor and insulin-like growth factor binding proteins, suggesting a regulatory role rather than bulk extracellular matrix degradation. When interpreting MMP-11 expression data, consider that elevated levels may reflect stromal remodeling and signaling rather than direct matrix breakdown. This distinction is important for understanding its role in cancer progression and fibrosis.

Validation imagery coming soon

Western blot validation figures for RP-MMP11 will be published here as they are produced in-house.

If you would like to see existing validation data for this antibody before publication, request a sample copy.

Also known as:

  • Matrix metalloproteinase-11
  • Stromelysin-3
  • MMP-11
  • SL-3
  • ST3
  • EC 3.4.24.-
  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →